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ABSTRACT: Artificial cells that encapsulate DNA-programmable
protein expression machinery are emerging as an attractive platform
for studying fundamental cellular properties and applications in
synthetic biology. However, interfacing these artificial cells with the
complex and dynamic chemical environment remains a major and
urgent challenge. We demonstrate that the repertoire of molecules
that artificial cells respond to can be expanded by synthetic RNA-
based gene switches, or riboswitches. We isolated an RNA aptamer
that binds histamine with high affinity and specificity and used it to
design robust riboswitches that activate protein expression in the
presence of histamine. Finally, the riboswitches were incorporated in artificial cells to achieve controlled release of an
encapsulated small molecule and to implement a self-destructive kill-switch. Synthetic riboswitches should serve as modular and
versatile interfaces to link artificial cell phenotypes with the complex chemical environment.
■ INTRODUCTION
Artificial cells are cell-like compartments that encapsulate
reactive components to mimic cellular behaviors such as
replication, metabolism, intercellular communication, and
environmental adaptation.1,2 The compartments can be
chemically analogous to those of biological cells such as
phospholipid bilayer vesicles and liposomes. Alternatively,
synthetic compartments such as polymersomes and colloido-
somes have been explored as artificial cell compartments.3
Similarly, the content of the artificial cells can be enzymes,4,5
DNA reaction networks,6 or even living cells.7 These artificial
cells serve as experimental platforms to study cellular behaviors
in a constructive (bottom-up) fashion, and as advanced
vehicles for applications such as drug delivery and
biosensors.8,9
Liposomes encapsulating in vitro transcription/translation
(IVTT) systems represent artificial cells that mimic the
physical compositions and the genetic machinery of natural
cells. These artificial cells can use DNA encoded information
to express arbitrary proteins inside liposomes.10−14 Therefore,
the potential functions or the phenotypes of this class of
artificial cells are limited only by the expressed proteins.
However, what is equally or perhaps more important is the
ability to control protein expression inside artificial cells. As
with natural cells, the ability to regulate gene expression in
response to chemical or physical signals is crucial for
adaptation of artificial cells to a dynamic environment.
Therefore, some efforts to transplant natural mechanisms to
control gene expression chemically to artificial cells have been
reported, for example, the quorum sensing systems based on
acyl homoserine lactone (AHL) signals and their associated
transcription factors (TFs),15−18 as well as other bacterial TFs
and their small molecule inducers such as isopropyl β-D-1-
thiogalactopyranoside (IPTG), tetracycline, and arabinose.19,20
However, the use of TF-based gene switches in artificial cells
can sometimes be complicated by the need to optimize
multiple parameters (amounts of TF and template, promoter
design, etc.) carefully, and they have not been engineered to
respond to novel chemical signals in artificial cells.
A promising alternative strategy to control gene expression
in artificial cells is to use riboswitches. Natural riboswitches
control gene expression in bacteria by binding small molecule
metabolites and ions in the 5′ UTR of mRNAs and modulating
translation efficiency or transcription elongation.21,22 The wide
variety of molecules recognized by RNA aptamers selected in
vitro23 offers appealing opportunities for engineering ribos-
witches that respond to new chemical signals. The lack of
protein factors is also favorable for artificial cells that suffer
limited protein synthesis capacity. Synthetic riboswitches have
been engineered based on natural and synthetic RNA aptamers
that bind small molecules to control gene expression in
bacteria.24,25 However, adaptation of riboswitches in artificial
cells has been limited. Martini and Mansy26 first demonstrated
the riboswitch function in phospholipid vesicles encapsulating
a reconstituted IVTT system (PURE system).27,28 The
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researchers observed ∼6-fold activation of a fluorescent
reporter protein (YPet) expression in a bulk IVTT system in
response to theophylline, but the induced expression level was
very low, and the expression level in vesicles was not
quantified. Lentini et al.29 and Adamala et al.19 later used the
theophylline riboswitch to control α-hemolysin (αHL)
expression in liposomes to release the coencapsulated IPTG
or doxycycline in response to theophylline to control
Escherichia coli or other artificial cells, respectively. While
these reports elegantly demonstrated the potential of
riboswitches to engineer chemically responsive artificial cells,
the riboswitch performance (ON/OFF ratio and induced
expression level) was rather poor, with a reported ON/OFF
ratio of ∼1.5 in Lentini et al.29 A similar riboswitch was also
used by Adamala et al.,19 but they did not directly report the
riboswitch performance. They observed ∼3-fold activation of
reporter gene expression in a cascaded gene circuit, which also
implicates poor riboswitch performance. Theophylline is also a
popular ligand for proof-of-principle riboswitch experiments
because it is one of the few small molecule−aptamer
combinations that have been shown to function in cells, but
there is little, if any, biological or technical significance as a
riboswitch ligand. More generally, relatively low ON/OFF
ratios and leaky expression (high OFF level) commonly
reported for synthetic riboswitches also likely to make their
applications in artificial cells more challenging.30 Conse-
quently, general utility of riboswitches as chemical gene
switches in artificial cells has not been demonstrated. More
broadly, there is currently a lack of general strategies to
interface artificial cells with the complex chemical environ-
ment.
To build artificial cells that respond to a biologically
significant chemical input by modulating gene expression, an
RNA aptamer must first be obtained by in vitro selection, or
systematic evolution of ligands by exponential enrichment
(SELEX).23 Subsequently, the aptamer needs to be engineered
to function as an effective riboswitch in an IVTT system, and
finally encapsulated in vesicles and characterized. Here, we
describe the first implementation of this design strategy for
artificial cells that genetically respond to a biologically
important small molecule for which there are no known TF-
based sensors. We chose to sense histamine (Figure 1a), a
natural signaling molecule involved in inflammatory response31
and a neurotransmitter.32 Histamine is produced by decarbox-
ylation of histidine (Figure 1a), and it is naturally sensed
extracellularly through G-protein coupled receptors
(GPCRs),33 which would be difficult to adapt to artificial
cells. We isolated a histamine specific aptamer by SELEX,
characterized it in vitro, and the aptamer was engineered to
function as robust riboswitches that induce protein expression
in the presence of histamine in a reconstituted IVTT system.
Finally, the riboswitch was fused to a reporter gene and other
genes, encapsulated in phospholipid vesicles, and the behavior
(phenotype) of the artificial cells was quantitatively charac-
terized. The series of experiments reported in this article
demonstrates for the first time that artificial cells can be
engineered to respond genetically to a small molecule even in
the absence of natural sensors adaptable to artificial cells and
paves the way for de novo design of artificial cells that can sense
and genetically respond to diverse chemical signals for various
applications.
■ RESULTS
In Vitro Selection of Histamine-Binding RNA Ap-
tamers. A histamine aptamer was selected from a pool of 2 ×
1015 RNA molecules containing up to 3 × 1014 unique
sequences within the 40-nt randomized region flanked by 21-
and 23-nt constant sequences at the 5′ and 3′ ends,
respectively (Table S1). As histamine is a small molecule
with few functionalities, L-histidine was immobilized on
agarose beads via its carboxyl group so that both the imidazole
and the amino groups of histamine would be available for the
Figure 1. Histamine aptamer. (a) Structures of histamine and L-histidine. (b) Sequence and a predicted secondary structure (by Mfold34) of
histamine binding aptamer A1. The blue nucleotides are from the constant regions in the RNA library. The red nucleotides represent the selected
sequence. The positions found to be highly variable (A34-G40) after reselection are shaded in gray. (c) Sequence and a predicted secondary
structure of a truncated aptamer A1-949. The circled cytidine was introduced to stabilize the putative stem structure. (d) ITC measurement of A1-
949 binding to histamine. (e) ITC measurement of A1-949 binding to L-histidine. Detailed results of ITC measurements are provided in Table S3.
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potential aptamers to interact (Figure 1a). Stringency of the
selection was gradually increased by additional washing steps,
introduction of negative selection against L-histidine (from
round 8), and lowering the histamine concentration in the
elution buffer (from round 9) (Table S2). RNA populations
before rounds 8, 9, and 11 were then analyzed by deep
sequencing and compared with RNA eluted from these
selection rounds by histamine as well as by L-histidine to
identify histamine-specific aptamer candidates.
Careful analysis of the sequencing results (Supporting Data
1) led us to A1 as a particularly promising candidate (Figure
1b). A1 was found to be the second most abundant sequence
in the histamine eluent from round 11, constituting 17.2% of
the sequenced population. On the other hand, A1 comprised
5.8% of the L-histidine eluent, indicating the preference of A1
to bind histamine. None of the other 12 sequences with
abundance >0.5% in the histamine eluent from round 11
showed comparable preference for histamine over L-histidine.
Furthermore, the abundance of A1 in the histamine eluent
progressively increased from 0.099% in round 8 to 0.33% in
round 9, and to 17.2% in round 11. Consequently, the full A1
sequence including the flanking constant regions was
synthesized by in vitro transcription and characterized by
isothermal titration calorimetry (ITC). A1 showed a
dissociation constant (Kd) of 0.4 μM for histamine and 47
μM for L-histidine, respectively (Figure S1), confirming its high
affinity for histamine and selectivity against L-histidine.
Minimization of A1 Aptamer. To identify the core
sequence of the aptamer necessary for histamine binding, a
partially randomized library of the A1 aptamer was prepared by
doping the selected bases at a rate of 21%. The library was
subjected to four rounds of stringent selection for histamine
binding (Table S2) and sequenced (Supporting Data 2). The
sequences which were enriched more than 50-fold after four
rounds of selection were analyzed to determine the variability
of each nucleotide in the aptamer sequence (Figure S2). C1
through G33 were generally well conserved with some
variability observed at U5, A16, A17, A18, and A26. However,
A34 through G40 were highly variable, indicating that these
positions are not critical for histamine binding. These
observations and the predicted secondary structure of the
Figure 2. Characterization of histamine riboswitches in IVTT. (a) Riboswitch design strategy. A part of the aptamer was designed to hybridize with
the leader peptide sequence in the coding region to sequester the SD sequence and the start codon from the ribosome. Aptamer-histamine binding
disrupts the secondary structure and increases the translation efficiency. (b) Screening of riboswitch variants based on the expression of mCherry
encoded downstream of each riboswitch. (c) Dose-dependence of the H2 riboswitch. (d) Mutational analysis of the H2 riboswitch in the histamine
aptamer. (e) Mutational analysis of the H2 riboswitch to probe the role of the designed stem structure. Sequences of the riboswitch constructs are
shown in Figure S5 and Supporting Note 1. (b−d) The samples were measured in duplicates (n = 2), and the error bars indicate the range of the
two measurements. (e) The samples were measured in triplicates (n = 3), and the error bars indicate s.d.
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full A1 sequence by Mfold34 (Figure 1b) led us to A1-949 as a
core aptamer sequence (Figure 1c).
ITC measurements of A1-949 yielded dissociation constants
(Kd) for histamine (0.37 μM) and L-histidine (23 μM), which
are comparable to those of A1 (Figure 1d,e). The
stoichiometry (N) was significantly lower than 1.0, which
may be due the formation of nonfunctional complexes. Native
gel electrophoresis of A1 showed multiple bands (Figure S3)
suggesting that the aptamer may form multiple secondary
structures or multimeric complexes, therefore lowering the
effective aptamer concentration capable of ligand binding. The
high RNA concentration (25−50 μM) necessary for accurate
ITC measurements further increases the probability of forming
intermolecular complexes. Similar deviations from the ideal
stoichiometry in small molecule binding RNA aptamers have
been reported previously.35 To support the ITC results, Cy5-
labeled A1-949 was chemically synthesized and was used to
measure the aptamer affinity by microscale thermophoresis
(MST), which yielded Kd values of 1.7 and 362 μM for
histamine and L-histidine, respectively (Figure S4). These
results confirm the high affinity of A1-949 for histamine and
high selectivity against L-histidine.
Engineering Histamine-Responsive Riboswitches.
With a histamine aptamer in hand, our next aim was to
engineer histamine-responsive riboswitches that function in a
reconstituted IVTT system. Bacterial riboswitches are typically
engineered by screening a large number of “expression
platform” sequences between an aptamer and a ribosome
binding site (RBS) in bacteria (mostly E. coli) using a reporter
gene or a selection marker.36,37 However, cell-based screening
was not a promising strategy for histamine riboswitches
because histamine is a polar molecule which is unlikely to
diffuse through the bacterial cell membrane. Furthermore, we
deemed it more appropriate to optimize the riboswitch
function in the environment in which the riboswitches are
intended to be used, namely, the IVTT system that would later
be encapsulated in liposomes to create programmable artificial
cells. For this purpose, DNA templates encoding the T7
promoter, a riboswitch, and mCherry sequences were
constructed (designated T7-[riboswitch]-mCherry) and eval-
uated using the PURE system28 (PUREf rex 1.0) for IVTT.
Our riboswitch design strategy was loosely based on the
previously described synthetic riboswitches isolated by screen-
ing or selection in E. coli.38,39 These riboswitches form a stable
secondary structure in the absence of the ligand that sequesters
the Shine-Dalgarno (SD) sequence and the start codon
(AUG), thereby translationally repressing protein expression.
Aptamer−ligand interaction interferes with this structure,
resulting in increased accessibility of the SD sequence and
the start codon to the ribosome to activate translation (Figure
2a). A unique feature of our design was to incorporate a leader
peptide coding region (∼27 nt including the start codon) that
forms a stable stem structure with part of the histamine
aptamer (Figure S5). This extra leader peptide was inserted
upstream of the native mCherry coding sequence, therefore
forming a part of the riboswitch module which needs to be
included when regulating another gene.
Riboswitches J1, H1, H2, and C2 (Figure S5, Supporting
Note 1) were designed to fold into similar structures using
RNAfold server in ViennaRNA Web Services,40 intended to
represent different local structures and stabilities. No attempt
was made to predict the secondary structures of the ligand-
bound riboswitches, as the accuracy and practical significance
of such structures are questionable. The four riboswitch
Figure 3. Programming artificial cells using a synthetic histamine-responsive riboswitch. By changing the protein whose expression is controlled by
the riboswitch, the artificial cells exhibit various phenotypes such as becoming fluorescently active, releasing a low molecular weight compound
trapped inside artificial cells, or activating a kill-switch leading to self-destruction, in response to histamine in the environment.
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candidates were evaluated in the presence (0.5 mM) and
absence of histamine (Figure 2b). While all four designs
responded to histamine by upregulating mCherry expression,
the riboswitch H2 (DNA template T7-H2-mCherry, Support-
ing Note 1) showed the highest ON/OFF ratio of 9.2. H2 was
further characterized under various histamine concentrations
(Figure 2c). This robust riboswitch yielded an ON/OFF ratio
as high as 30.7 (Figure 2d) albeit at a relatively high histamine
concentration (5 mM). It was also confirmed that H2 does not
respond to L-histidine, D-histidine, and imidazole (Figure S6).
To rule out nonspecific activation of gene expression by
histamine, single-base mutations were introduced within the
conserved nucleotides in the aptamer in the H2 riboswitch.
The mutant riboswitches H2-M8 and H2-M21 (Supporting
Note 1) both failed to activate gene expression in the presence
of histamine (Figure 2d). Another control construct (OptRBS)
lacking the histamine aptamer and harboring an optimal RBS
sequence suggested by the RBS Calculator41 showed strong
mCherry expression with or without histamine. These results
clearly confirm that the riboswitch function is dependent on
the specific interaction between the aptamer and histamine.
Moreover, the induced expression level is comparable to that
of an efficiently translated mRNA (OptRBS) (Figure 2d). The
riboswitches H2 and J1 were also tested in a cell extract-based
IVTT system (E. coli S30 Extract, Promega) transcribed from
the tac promoter by E. coli RNA polymerase (Figure S7) and
were confirmed to be functional.
To support further the proposed riboswitch mechanism, we
prepared several mutants of H2 in which the stem between a
part of the aptamer and the leader coding sequence was
progressively weakened. W1 and W2 each contains one
mismatch resulting from a single-base, synonymous mutation
in the leader peptide region (Figure S5). These mutants
showed moderate increases in mCherry expression both in the
absence and presence of histamine (Figure 2e). The two
mutations were combined in W3, which resulted in a
significant degradation of the performance as a switch (Figure
2e).
The robust riboswitches that function in the IVTT system
allow us to program the artificial cells to perform various tasks
in response to histamine by controlling expression of different
proteins. To demonstrate the versatility of riboswitches to
program artificial cells, we designed artificial cells that simply
express a reporter gene, release small molecule cargo, or self-
destruct in response to histamine (Figure 3).
Construction and Characterization of Histamine-
Responsive Artificial Cells. We first aimed to investigate
whether the artificial cells harboring T7-H2-mCherry can
respond to the histamine added to the external solution of
artificial cells (Figure 3, top panel). Artificial cells were
Figure 4. Histamine-responsive expression of mCherry in artificial cells. (a) The two-dimensional plots show the relationship between OA647
fluorescence intensity, representing the aqueous volume of the liposome, and mCherry fluorescence intensity. (b) Time course of the median value
of mCherry/OA647 fluorescence intensity which represents the relative mCherry concentration inside the liposome. The error bars represent the
s.e. calculated from 20 000 particle data obtained by FCM. A similar result was observed in the technical repeat experiment (Figure S8a). (c)
Confocal imaging of artificial cells with or without histamine exposure. (d) The effect of removal and addition of histamine during mCherry
synthesis. Histamine was removed by pelleting the artificial cells by centrifugation and exchanging the supernatant with the buffer without
histamine. The arrow indicates the time when histamine was added or removed. The error bars represent the s.e. calculated from 20 000 particle
data obtained by FCM. A similar result was observed in the technical repeat experiment (Figure S8b).
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prepared by encapsulating T7-H2-mCherry DNA together
with the reconstituted IVTT into the liposome. As a
fluorescent protein marker, ovalbumin conjugated to Alexa-
Fluor647 (OA647) (45 kDa) was also included to indicate the
aqueous volume of the liposomes. Histamine (10 mM) was
added to the external solution of the liposomes, incubated at
37 °C to initiate the protein synthesis, and mCherry
fluorescence was evaluated using flow cytometry (FCM) and
confocal fluorescence microscopy (Figure 4). FCM data
showed that mCherry fluorescence of the liposomes increased
over time when histamine was present (Figure 4a). T7-H2-
mCherry yielded an ON/OFF ratio as high as 30.3 after 20 h
of incubation (Figure 4b), a value similar to that obtained in a
batch reaction (Figure 2b). Confocal fluorescence imaging
showed that mCherry was synthesized and distributed
uniformly inside the liposome in the presence of histamine
(Figure 4c). These results show that the riboswitch H2 also
functions inside liposomes.
To demonstrate the switching ability of protein expression
inside the artificial cells, histamine was first added to the
external solution of artificial cells and was then removed after 2
h. The mCherry fluorescence increase terminated after 4 h
(Figure 4d). The observed delay in the termination is likely
due to the slow folding of mCherry,42 i.e., mCherry synthesis
stopped after 2 h incubation but mCherry folding continued
for additional 2 h. Conversely, histamine was added for the first
time after 2 h incubation at 37 °C. The mCherry fluorescence
hardly increased during the first 2 h, whereas a clear increase
was observed after the addition of histamine (Figure 4d).
These results clearly demonstrate that histamine is membrane-
permeable, and the expression in artificial cells can be
dynamically controlled by the addition or removal of
histamine.
The FCM analysis revealed that more than 80% of the
artificial cells showed detectable mCherry fluorescence in the
presence of histamine (Figure S9a). The artificial cells used in
this study were prepared using the water-in-oil (W/O)
emulsion/transfer method43 (see Methods for details), and
the aqueous volume of cells prepared in this way was reported
to be between 1 to 100 fL.44,45 The template DNA is the IVTT
component with the lowest concentration at 5 nM, which
corresponds to on average 3 to 300 copies per liposome. This
implies that even the smallest artificial cells contain all IVTT
components at similar concentrations which is consistent with
our observation that the majority of the artificial cells showing
detectable mCherry fluorescence in the presence of histamine
(Figure S9a).
Controlled Release of Small Molecule Cargo by
Artificial Cells. With a robust riboswitch that functions in
liposomes in hand, we sought to use the riboswitch to regulate
other genes to confer new phenotypes to the artificial cells.
First, we used the H2 riboswitch to control an engineered
version of the α-hemolysin (αHL)46 pore-forming protein
from Staphylococcus aureus. Addition of histamine activates the
Figure 5. Histamine-responsive expression of αHL in artificial cells and selective release of calcein. (a) The two-dimensional plots show the
relationship between OA647 fluorescence intensity, representing the aqueous volume of the liposome, and calcein fluorescence intensity. (b) Time
course of the median value of calcein/OA647 fluorescence intensity, which represent the relative calcein concentration inside the liposome. The
error bars represent the s.e. calculated from 20 000 particle data obtained by FCM. A similar result was observed in the technical repeat experiment
(Figure S8c). Histograms of the (c) calcein, (d) OA647, and (e) calcein/OA647 fluorescence of the two-dimensional plots shown in panel a. (f)
Confocal images of artificial cells with or without histamine exposure.
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riboswitch to express αHL within the liposomes. The pore-
forming αHL proteins are incorporated into the lipid bilayer of
the liposomes, which allow diffusion of small molecules less
than ∼3 kDa across the liposomal membrane, but macro-
molecules such as proteins remain in the artificial cells (Figure
3, middle panel). In other words, artificial cells can be
chemically triggered to release encapsulated small molecules.
DNA template T7-H2-αHL was encapsulated in artificial cells
along with the reconstituted IVTT mixture, OA647 (45 kDa),
and calcein (623 Da). Calcein does not diffuse through lipid
bilayer and emits green fluorescence, therefore serving as
model small molecule cargo, while OA647 is expected to
remain in the liposomes even when αHL is expressed.
Histamine (10 mM) was added to the external solution of
the liposomes, incubated at 37 °C to initiate the protein
synthesis, and the fluorescence was evaluated using FCM and
confocal fluorescence microscopy (Figure 5).
The FCM data showed a decrease in calcein fluorescence
while that of OA647 remained unchanged during the
incubation (Figure 5a,c,d) in the presence of histamine. This
result indicates the nanopore formation by αHL. Conse-
quently, a 17-fold decrease in the median value of the relative
concentration of calcein inside the liposome was observed
(Figure 5b). The FCM data indicate more than 80% of the
artificial cells show detectable decrease in calcein fluorescence
(Figure S9b). The result was further confirmed by confocal
fluorescence imaging where both calcein and OA647
fluorescence was observed in the absence of histamine,
whereas the depletion of calcein fluorescence was observed
in the presence of histamine (Figure 5e). These results show
that the artificial cells can be programmed to release small
molecules in response to histamine via the synthetic
riboswitch.
Histamine Induced Self-Destruction of Artificial Cells.
Self-destruction of artificial cells can also be induced by
histamine (Figure 3, bottom panel). DNA encoding the T7
promoter, H2 riboswitch, and phospholipase C (PLC),47 an
enzyme that cleaves phospholipids before the phosphate, was
constructed (T7-H2-PLC). Artificial cells were prepared by
encapsulating T7-H2-PLC DNA together with the reconsti-
tuted IVTT, OA647, and calcein. Histamine (10 mM) was
added to the external solution of the liposomes, incubated at
37 °C to initiate the protein synthesis, and the fluorescence
was evaluated using FCM and confocal fluorescence
microscopy (Figure 6).
The FCM data showed a decrease in the population of
liposomes with strong calcein and OA647 fluorescence
intensity (Figure 6a) in the presence of histamine. The
fraction of liposomes in Gate A showed a much greater
decrease in the presence of histamine compared to those
without histamine and without T7-H2-PLC (Figure 6b). In
addition, fluorescence of both calcein and OA647 decreased
during the incubation (Figure 6c,d). The result was also
confirmed by confocal fluorescence imaging where both
Figure 6. Histamine-responsive expression of PLC in artificial cells as a kill-switch. (a) The two-dimensional plots show the relationship between
OA647 fluorescence intensity representing the aqueous volume of the liposomes and calcein fluorescence intensity. (b) Time course of the fraction
of liposome present in Gate A. Each data point represents mean ± s.e. of three independent measurements. Histograms of (c) calcein and (d)
OA647 fluorescence of the two-dimensional plots shown in Figure 6a. (e) Confocal images of artificial cells with or without histamine exposure.
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calcein and OA647 fluorescence was observed in the absence
of histamine, whereas the liposomes were hardly detectable
and only membrane fragments were observed in the presence
of histamine (Figure 6e). These observations are consistent
with physical destruction of the artificial cells. We performed
similar experiments using phospholipase A1 (PLA1)48 which
cleaves the acyl chain of the phospholipid. In this experiment,
the liposomes were prepared using a fluorescently labeled
(green) lipid to detect the membrane rupture directly (Figure
S10). In the presence of histamine, a decrease in green
fluorescence was observed by FCM, again indicating self-
destruction of the artificial cells (Figure S10a). These results
show that the artificial cells can be programmed to self-destruct
(suicide) in response to histamine via the synthetic riboswitch.
■ DISCUSSION
The ability to sense and genetically respond to chemical signals
inside and outside of cells is crucial for both natural and
artificial cells. However, the current scarcity of genetic devices
that can interface artificial cells with the complex chemical
environment will likely limit the future applications of artificial
cells. Riboswitches have a number of desirable properties as
chemical gene switches in artificial cells. First, the well-
established technique of in vitro selection of RNA aptamers
from a pool of random sequences should allow development of
RNA aptamers for a variety of chemical signals.23 Second,
development of riboswitches using natural and synthetic RNA
aptamers have been reported extensively in bacteria.24,25
Finally, riboswitches require no protein cofactors that need
to be expressed intracellularly or added in pure form. These
characteristics should allow engineering of riboswitches that
respond to desired chemical signals by expressing arbitrary
proteins in artificial cells. In practice, however, only the
theophylline riboswitches with modest performance have been
used to control gene expression in artificial cells,19,26,29 and the
often-stated promise of riboswitches enabling artificial cells to
sense and respond to the complex extra- and intracellular
chemical environments has not been substantiated.
The newly isolated histamine aptamer was successfully
converted into synthetic riboswitches with high ON/OFF
ratios, up to 30.7 and 30.3 in batch and in artificial cells,
respectively. Furthermore, induced expression levels (ON
level) was nearly identical to the construct with an optimal
RBS sequence (and no riboswitch) in a bulk IVTT system
(Figure 2). Riboswitches with such high ON/OFF ratios and
expression levels are uncommon. However, our riboswitches
require ∼1 mM histamine for ∼10-fold activation of gene
expression (Figure 2b,c), which is significantly high (histamine
concentration) considering the low Kd of the aptamer. Similar
discrepancies between the aptamer−ligand affinity and the
riboswitch response have been observed in natural and
synthetic riboswitches in bacteria,49,50 which have been
attributed to the existence of competing RNA structures and
kinetic control. While we opted for few cycles of trial-and-error
to discover several robust riboswitches, high-throughput
screening methods in IVTT would be desirable to engineer
more sensitive riboswitches for artificial cell applications. For
example, liposome display technology46,51 may be used to
engineer riboswitches that show superior expression at lower
histamine concentrations. Alternatively, genetic circuits such as
the positive feedback loop may be used to amplify the
riboswitch response.20 Our histamine riboswitch also func-
tioned in liposomes without further optimization. Histamine
was found to diffuse through the phospholipid bilayer (Figure
4d). For chemical inputs that have lower permeability across
artificial cell membrane, modifications such as membrane
incorporation of protein pores or transporters may be
necessary. A significant improvement in sensitivity is necessary
for the riboswitch-engineered artificial cells to sense bio-
logically relevant histamine concentrations; a recent GPCR-
based histamine sensor constructed in mammalian cells
showed an EC50 of ∼100 nM histamine.52
Histamine is naturally sensed by the membrane-integrated
GPCRs, and it is not known to be membrane permeable.
However, histamine was found to penetrate the membrane of
the artificial cells passively. We showed that mCherry
expression, release of an encapsulated small molecule, and
self-destruction occur only when histamine was added to the
external solution of the artificial cells (Figures 4−6).
Furthermore, addition or removal of histamine to or from
the external solution of the artificial cells resulted in initiation
or termination of mCherry expression, respectively (Figure
4d). This observed switching behavior of the riboswitch-
containing artificial cells clearly demonstrates that histamine
diffuses through the artificial cell membrane. Similarly, many
amino acids have been shown to permeate the artificial cell
membrane,53 while natural cells use transporters to transport
amino acids. The natural and artificial cells have significant
differences in the membrane structure. Artificial cell membrane
used in this study is composed of purified phosphatidylcholine
and cholesterol, while that of the natural cells consist of various
phospholipids, integral membrane proteins, and lipid asso-
ciated proteins. The lack of such complex structures in artificial
cells is likely to have affected the membrane permeability of
histamine.
The riboswitches, through the aptamer domain, offer
opportunities to interface artificial cells with numerous intra-
or extracellular chemical signals. The output of the interface is
(conditional) expression of arbitrary proteins which also opens
the door to many possible outcomes (phenotypes) (Figure 3).
In this work, in addition to fluorescent protein expression
(Figure 4), we demonstrated conditional release of a small
molecule (calcein) trapped inside artificial cells via riboswitch-
activated expression of αHL. Other canonical gene switches
have been used to control αHL expression in liposomes.18,19,29
While these earlier studies demonstrated the use of αHL to
release small molecules encapsulated in artificial cells, the
process was not thoroughly characterized. For example, while
Tang et al. measured the dequenching of the released calcein in
the outer bulk solution,18 we directly measured the
fluorescence distribution of the artificial cells by FCM.
Similarly, the release of entrapped IPTG through αHL was
indirectly monitored by the activation of GFP expression in
cocultured E. coli by Lentini et al.,29 and the released
doxycycline was indirectly detected by reporter gene
expression in other artificial cells by Adamala et al.19 In this
work, we directly and quantitatively observed the controlled
release of a small-molecule compound (but not proteins)
encapsulated in artificial cells in the presence of histamine by
fluorescence microscopy and FCM (Figure 5), observing about
a 20-fold decrease in the calcein concentration upon riboswitch
activation.
Robust chemically controlled release of molecular cargo may
be useful for drug delivery and other applications. Histamine is
released by mast cells and basophils in response to antigen
exposure.31 A possible future direction is to program artificial
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cells to respond to histamine released by mammalian cells by
delivering antihistamine or anti-inflammatory drugs. We
demonstrated another phenotype by fusing the riboswitch to
a gene encoding PLC (Figure 6) and PLA1 (Figure S10). By
catalyzing phospholipid hydrolysis, phospholipase expression
was expected to result in disintegration of the artificial cells.
We envisioned it as a model of a “kill-switch” which can be
used to program artificial cells to self-destruct after their
intended tasks are completed, or when they result in
undesirable or unexpected consequences and need to be shut
down. As expected, activation of phospholipase expression
resulted in degradation of the artificial cells as observed by
FCM and fluorescence microscopy (Figure 6, Figure S10).
Taken together, these results support the modularity of
riboswitches to control expression of arbitrary proteins in
response to an aptamer ligand, thereby greatly expanding the
potential phenotypes that can be controlled by chemical
signals. However, such practical applications of chemically
responsive artificial cells will need to overcome various
technical challenges, for example, long-term stability of the
artificial cells, and toxicity and immunogenicity of the
expressed proteins. Because riboswitches function inside
artificial cells, additional protein devices such as transporters
or pore-forming membrane proteins may be necessary to sense
molecules that do not efficiently diffuse across lipid bilayers
using riboswitches.
In conclusion, we addressed one of the significant and
imminent challenges for artificial cell research and applications,
namely, to interface them with the complex and diverse
chemical signals. We demonstrated the possibilities of
riboswitches as a promising chemical interface to connect
arbitrary chemical signals (via developing new RNA aptamers)
with arbitrary genetic output (proteins) to program artificial
cells.
■ METHODS
Oligonucleotides and Molecular Biology Reagents. A DNA
library with 40 degenerate bases flanked by constant sequences
(tempN40) and the primers (RevSel and T7-prom-fwd) for reverse
transcription and polymerase chain reaction (PCR) during SELEX
were purchased from Trilink Biotechnologies (Table S1). Partially
randomized DNA based on the A1 aptamer sequence (RC-temp-A1-
doped) was synthesized by GeneDesign and contained 79% original
(A1 aptamer) base mixed with 7% each of the remaining three bases
(Table S1). OneTaq 2X Master Mix (NEB) and Q5 High-Fidelity 2X
Master Mix (NEB) were used for PCR in SELEX and sequencing
library preparation, respectively. Reverse transcription reactions were
performed using Maxima H Minus Reverse Transcriptase (Thermo
Scientific). HiScribe T7 Quick High Yield RNA Synthesis Kit (NEB)
was used for in vitro transcription of the RNA pool for the first SELEX
round, and T7 RNA polymerase (NEB) was used for the subsequent
rounds.
Immobilization of Histidine on Agarose Beads. To make
both the imidazole and amino groups of histamine available for
aptamers to bind, L-histidine was immobilized via its carboxyl group.
EAH Sepharose 4B (GE Healthcare) bearing amino groups was
employed as an immobilization matrix. Fmoc-L-histidine (Watanabe
Chemical Industry) was coupled to the matrix as previously
described.54 Briefly, 10 mL of EAH Sepharose 4B was transferred
to a PD-10 column (GE Healthcare) and washed twice with 5 mL of
N,N-dimethylformamide (DMF) (Nacalai). The matrix was sus-
pended in 5 mL of DMF containing 30 μmol of Fmoc-L-histidine and
30 μmol of benzotriazol-1-yl-oxytripyrrolidinophosphonium hexa-
fluorophosphate (PyBOP) (Watanabe Chemical Industry). A total of
500 μmol of diisopropylethlamine (DIPEA) (Nacalai) was slowly
added while stirring, and the reaction was allowed to proceed for 2 h
at 24 °C. After washing the matrix with DMF (2× 5 mL), it was
incubated for 30 min with 5 mL of DMF containing 2 mmol of acetic
anhydride (Nacalai) and 2 mmol DIPEA to block the unreacted
amino groups on the beads. After washing the matrix with DMF (4×
5 mL), it was treated twice with 5 mL of 20% piperidine (Nacalai) in
DMF for 10 min to remove the Fmoc group. The eluents from the
two piperidine treatments were combined and the absorbance of the
solution at 301 nm (εM = 9700)
54 was measured using 20% piperidine
in DMF as a blank to determine the amount of the released Fmoc to
calculate the coupling efficiency. It was determined that 14.2 μmol of
histidine was coupled, which corresponds to approximately 19% of the
amino groups on the matrix. The counterselection matrix was
prepared in parallel using the same method except in the absence of L-
histidine.
SELEX Procedure. The DNA library template tempN40 (0.5
nmol, 3 × 1014 molecules) and RevSel (1 nmol) were mixed in a total
volume of 1.5 mL using OneTaq 2X Master Mix (NEB). The mixture
was denatured at 94 °C for 4 min followed by four cycles of 94, 48,
and 68 °C for 30 s each. Subsequently, 2 nmol of T7-prom-fwd was
added and four additional thermal cycles were performed to generate
the template for in vitro transcription. The template DNA was column
purified (DNA Clean & Concentrator-5, Zymo Research), and 20 μg
was used for an overnight RNA transcription reaction in 270 μL
volume using HiScribe T7 High Yield RNA Synthesis Kit (NEB). The
RNA solution (250 μL) was then mixed with 125 μL of 10× DNase I
buffer and treated with 20 U of DNase I (NEB) in a total volume of
1250 μL for 1 h at 37 °C. The RNA was then recovered by ethanol
precipitation.
The random RNA pool (110 μg corresponding to approximately
2.3 × 1015 molecules) was dissolved in 2.5 mL of the selection buffer
(50 mM HEPES pH 7.0, 250 mM NaCl, and 2 mM glycine), heated
to 70 °C for 10 min, and slowly cooled to room temperature. The
RNA solution was then supplemented with MgCl2 (5 mM) and CaCl2
(5 mM). The RNA library was incubated with 500 μL of the L-
histidine-coupled Sepharose matrix in a PD-10 column for 1 h at 37
°C. The unbound RNA molecules were washed once using 0.5 mL of
the selection buffer (with MgCl2 and CaCl2), and the bound
sequences were eluted using 2× 1 mL of the selection buffer (with
MgCl2 and CaCl2) containing 10 mM histamine. The eluted RNA
molecules were then ethanol precipitated after the addition of Quick-
Precip Plus Solution (EdgeBio). The recovered RNA pool was reverse
transcribed, PCR amplified, and in vitro transcribed to produce the
RNA pool for the second round. Starting from the second round, 1.5
μg of RNA dissolved in 2 mL of selection buffer was applied to the
matrix, and each cycle was preceded with a counterselection in 500 μL
of the acetylated matrix. Starting from the fourth round, mutagenic
PCR was performed to increase the diversity of the library.55 A
negative selection step using L-histidine was also included from round
8. Histamine concentration during the elution step was reduced to 0.2
mM in rounds 9−11. From round 4, CaCl2 was removed from the
buffer and MgCl2 concentration was gradually reduced. Other
selection conditions for each round are summarized in Table S2.
Three columns were used in rounds 8, 9, and 11 for SELEX and to
prepare sequencing samples. One column was used for regular SELEX
with a negative selection using L-histidine and eluted with histamine.
The resulting RNAs were used for the subsequent round of SELEX.
The second column was used to perform the same SELEX procedure,
but the bound RNA was eluted with histidine (0.2 mM) after the
buffer wash step. The third column was similarly eluted with
histamine (0.2 mM) after the buffer wash without a negative selection
step using histidine. The latter two eluents and the RNA pool before
selection from these rounds were separately reverse transcribed and
PCR amplified to attach barcodes adapter sequences for deep
sequencing. The sequencing samples were analyzed by Illumina
MiSeq DNA sequencer using MiSeq Reagent Kit v3. Sequences with
more than 10 reads in the histamine elution from round 11 were
compiled and shown in Supporting Data 1.
Reselection of Partially Randomized A1 Aptamer. A doped
RNA library based on the A1 aptamer selected from the random RNA
pool was prepared by annealing and extending oligonucleotides T7-
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prom-fwd and RC-temp-A1-doped (Table S1). The selection buffer
contained HEPES (50 mM, pH 7.0), NaCl (250 mM), MgCl2 (0.1
mM), and glycine (2 mM). The procedure was similar to the original
selection with the following exceptions. The first round was
performed using 100 μg of RNA dissolved in 6 mL, and the
subsequent rounds were performed using 10 μg of RNA in 2 mL.
More stringent histidine negative selections were performed, starting
with 1 mM in the first round and 50 mM in the fourth round.
Detailed selection conditions are summarized in Table S2. The initial
RNA library before SELEX and the eluted RNA pools after each
round were analyzed by deep sequencing as described above.
Sequences with more than five reads in the final round of the
selection were compiled and summarized in Supporting Data 2.
Isothermal Titration Calorimetry (ITC). Both the A1 aptamer
and the minimized A1-949 aptamer were transcribed in vitro using the
HiScribe T7 Quick High Yield RNA Synthesis Kit (NEB) according
to the manufacturer’s instructions and treated by DNase I. The RNA
solutions were treated with phenol/chloroform and precipitated with
ethanol. The aptamers were dissolved in the buffer used in SELEX
and concentrated using 4 mL Amicon Ultra Centrifugal Filters
(Merck) with a 3 kDa cutoff to remove any remaining truncated
transcripts and nucleotides. ITC measurements were performed using
MicroCal PEAQ-ITC (Malvern). The RNA aptamer was added in the
cell while the ligand (histamine or L-histidine) was titrated from the
syringe. The cell temperature was maintained at 25 °C. Control
reactions in which the ligand was titrated against the buffer, the buffer
was titrated against the RNA solution, and the buffer was titrated
against the buffer were also performed and used to correct the
baseline.
Microscale Thermophoresis (MST). A1-949 (Figure 1c)
modified with Cy5 at the 5′ terminus (Cy5-A1-949) was synthesized
and high performance liquid chromatography purified by FASMAC.
The binding for both histamine and L-histidine was measured using
the same buffer used for the SELEX at 25 °C. The experiment was
performed by 2bind GmbH.
Riboswitch Design and Evaluation in IVTT System. The
mCherry coding sequence was PCR amplified from plasmid Psup-
1753-mCherry,56 and PLC and PLA1 sequences were synthesized by
IDT according to the published sequences.47,48 Riboswitches were
designed semirationally with the aid of RNAfold server in ViennaRNA
Web Services.40 The DNA templates encoding the T7 promoter, a
riboswitch, and a gene of interest were cloned in a plasmid vector and
sequence verified. The plasmids were then used as templates in PCR
to generate linear DNA templates (Supporting Note 1) for IVTT.
IVTT reactions were performed using PUREf rex 1.0 (GeneFrontier)
at a 10 μL volume containing 120 ng of a DNA template and an
appropriate concentration of histamine. The solutions were incubated
for 4 h at 37 °C in a thermal cycler (Bio-Rad T100), and 8 μL
aliquots were transferred to a low-volume 384-well plate. mCherry
fluorescence (587 nm excitation/610 nm emission) was measured in a
Tecan M1000PRO microplate reader.
Protein Synthesis Inside Liposomes. DNA templates used for
IVTT inside liposomes were T7-H2-mCherry, T7-H2-αHL, T7-H2-
PLA1, and T7-H2-PLC (Supporting Note 1). Liposomes containing a
reconstituted IVTT (PUREf rex1.0 or 2.0) were prepared using the
water-in-oil (W/O) emulsion/transfer method43 as previously
described.44,45 PUREf rex1.0 was used for mCherry and PLA1
synthesis and PUREf rex2.0 was used for αHL and PLC synthesis.
Briefly, 20 μL of reconstituted IVTT was supplemented with 5 nM
(mCherry and αHL) or 3 nM (PLC and PLA1) template DNA, 400
mM sucrose, 250 mM potassium glutamate, 0.8 U/μL RNase
inhibitor, and 1.5 μM ovalbumin Alexa Fluor 647 conjugate (OA647,
Thermo Fisher). When necessary, 5 μM calcein was added. In
addition, 0.5 mM CalCl2 was added when synthesizing PLA1 or PLC.
To this, IVTT solution, 200 μL of liquid paraffin (Wako) containing
0.77 mg of egg phosphatidylcholine (egg PC) (NOF Co.) and 0.77
mg of cholesterol (chol) (Sigma-Aldrich) were added. When labeling
the membrane with fluorescence, 0.2 mg of β-BODIPY[R]-FL-C12-
HPC (2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-
dodecanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine) was
added. The mixtures were vortexed for 30 s to form W/O emulsions
that were then equilibrated on ice for 10 min. The solution was gently
placed on top of 200 μL of the outer solution (see below for the
composition) and centrifuged at 15,000 g for 30 min at 4 °C. The
pelleted liposomes were collected through an opening at the bottom
of the tube. Proteins were synthesized by incubating the liposomes at
37 °C. The outer solution contained the low-molecular weight
components of reconstituted IVTT (0.3 mM each amino acid, 3 mM
ATP, 3 mM GTP, 1 mM CTP and UTP, 2 mM spermidine, 20 mM
creatine phosphate, 2 mM dithiothreitol (DTT), 0.02 μg/μL 10-
formyl-5,6,7,8-tetrahydrofolic acid, 250 mM potassium glutamate, 18
mM Mg(OAc)2, 400 mM glucose and 200 mM HEPES (pH 7.6)).
FCM Analysis and Confocal Microscopy. The liposomes were
analyzed by FCM using a CytoFlexS (Beckman Coulter, Fullerton,
CA) or FACSVerse; (BD). Before FCM analysis, the liposome
suspension was diluted 40-fold or 80-fold in a dilution buffer (20 mM
HEPES-KOH (pH 7.6), 250 mM potassium glutamate, 18 mM
Mg(OAc)2, and 400 mM glucose). A total of 20 000 liposomes were
measured. Fluorescence images of the liposome membrane were
obtained using a confocal laser scanning microscope (TCS SP8, Leica
Microsystems) and a 100× oil immersion objective.
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